Tricuspid regurgitation predicts mortality after liver transplantation in patients with high MELD score: A retrospective cohort study.

Tricuspid regurgitation and pulmonary artery systolic pressure may contribute to post-operative morbidity and mortality in liver transplantation. Previous studies suggest that a high Model for End-stage Liver Disease score may influence the relationship between tricuspid regurgitation and post-operative mortality. Adult patients undergoing liver transplantation workup between 2010 and 2023 were included in this retrospective observational cohort study. Patients with significant portopulmonary hypertension were excluded. Transthoracic echocardiograms were completed pre-transplant, and patients were followed up for 1 year post-operatively. In all, 1031 patients (median MELD score 17, IQR 12-23) underwent transthoracic echocardiography for liver transplantation workup, of whom 708 underwent successful transplantation. Mild or greater tricuspid regurgitation did not predict 1-year mortality in the overall population [HR 1.79 (95% CI 0.78-4.11), p =0.19]. Among patients with MELD scores ≥20, mild or greater tricuspid regurgitation was a significant predictor of 1-year mortality [7 (12.7%) vs. 9 (3.8%), p =0.01] [HR 3.46 (1.30-10.32), p =0.02]. Tricuspid regurgitation in patients with high MELD scores was associated with a trend toward an increased risk of 30-day major adverse cardiovascular events [9 (16.4%) vs. 46 (8.1%), p =0.06], driven predominantly by rates of post-operative heart failure [12.7% vs. 3.8%, HR 3.66 (95% CI 1.30-10.32), p =0.01]. Elevated pulmonary artery systolic pressure was associated with prolonged hospital stay [30 d (14-46) vs. 15 d (11-29), p =0.01]. Our study confirms that mild or greater tricuspid regurgitation is a significant predictor of 1-year mortality in patients with high MELD scores undergoing liver transplantation. Tricuspid regurgitation severity should be considered during pre-liver transplantation risk stratification.